GlaxoSmithKline Stock Forecast, Price & News

GlaxoSmithKline (NYSE:GSK) Frequently Asked Questions

Is GlaxoSmithKline a buy right now?

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for GlaxoSmithKline in the last twelve months. There are currently 2 sell ratings, 5 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" GlaxoSmithKline stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GSK, but not buy additional shares or sell existing shares.
View analyst ratings for GlaxoSmithKline or view top-rated stocks.

What stocks does MarketBeat like better than GlaxoSmithKline?

Wall Street analysts have given GlaxoSmithKline a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but GlaxoSmithKline wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is GlaxoSmithKline's next earnings date?

GlaxoSmithKline is scheduled to release its next quarterly earnings announcement on Wednesday, October 27th 2021.
View our earnings forecast for GlaxoSmithKline.

How were GlaxoSmithKline's earnings last quarter?

GlaxoSmithKline plc (NYSE:GSK) posted its quarterly earnings results on Wednesday, July, 28th. The pharmaceutical company reported $0.79 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.54 by $0.25. The pharmaceutical company earned $11.31 billion during the quarter, compared to analysts' expectations of $10.55 billion. GlaxoSmithKline had a trailing twelve-month return on equity of 26.21% and a net margin of 13.40%.
View GlaxoSmithKline's earnings history.

How has GlaxoSmithKline's stock been impacted by Coronavirus (COVID-19)?

GlaxoSmithKline's stock was trading at $39.87 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, GSK stock has decreased by 3.7% and is now trading at $38.39.
View which stocks have been most impacted by COVID-19.

How often does GlaxoSmithKline pay dividends? What is the dividend yield for GlaxoSmithKline?

GlaxoSmithKline announced a quarterly dividend on Friday, July 30th. Stockholders of record on Friday, August 20th will be paid a dividend of $0.523 per share on Thursday, October 7th. This represents a $2.09 annualized dividend and a dividend yield of 5.45%. The ex-dividend date of this dividend is Thursday, August 19th.
View GlaxoSmithKline's dividend history.

Is GlaxoSmithKline a good dividend stock?

GlaxoSmithKline pays an annual dividend of $2.09 per share and currently has a dividend yield of 5.31%. GSK has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. GlaxoSmithKline does not yet have a strong track record of dividend growth. The dividend payout ratio of GlaxoSmithKline is 70.13%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, GlaxoSmithKline will have a dividend payout ratio of 68.08% next year. This indicates that GlaxoSmithKline will be able to sustain or increase its dividend.
View GlaxoSmithKline's dividend history.

Who are GlaxoSmithKline's key executives?

GlaxoSmithKline's management team includes the following people:

• Emma N. Walmsley, Chief Executive Officer & Executive Director
• Iain James Mackay, Chief Financial Officer & Executive Director
• Jon Ellis, VP & Head-Technology Business Development
• Karenann K. Terrell, Chief Digital & Technology Officer
• Hal V. Barron, Executive Director & Chief Scientific Officer

Who are some of GlaxoSmithKline's key competitors?

Some companies that are related to GlaxoSmithKline include Roche (RHHBY), Pfizer (PFE), Novo Nordisk A/S (NVO), Eli Lilly and (LLY), Abbott Laboratories (ABT), AbbVie (ABBV), AstraZeneca (AZN), Merck & Co., Inc. (MRK), Novartis (NVS), Bristol-Myers Squibb (BMY), Sanofi (SNY), CSL (CSLLY), Zoetis (ZTS), Regeneron Pharmaceuticals (REGN) and Bayer Aktiengesellschaft (BAYRY).
View all of GSK's competitors.

What other stocks do shareholders of GlaxoSmithKline own?

Based on aggregate information from My MarketBeat watchlists, some companies that other GlaxoSmithKline investors own include AT&T (T), Pfizer (PFE), Johnson & Johnson (JNJ), Verizon Communications (VZ), Cisco Systems (CSCO), AbbVie (ABBV), Intel (INTC), Gilead Sciences (GILD), The Walt Disney (DIS) and NVIDIA (NVDA).

What is GlaxoSmithKline's stock symbol?

GlaxoSmithKline trades on the New York Stock Exchange (NYSE) under the ticker symbol "GSK."

Who are GlaxoSmithKline's major shareholders?

GlaxoSmithKline's stock is owned by a number of retail and institutional investors. Top institutional investors include Dodge & Cox (3.28%), Capital International Investors (0.84%), Fisher Asset Management LLC (0.65%), FMR LLC (0.63%), Price T Rowe Associates Inc. MD (0.54%) and Hotchkis & Wiley Capital Management LLC (0.35%).
View institutional ownership trends for GlaxoSmithKline.

Which institutional investors are selling GlaxoSmithKline stock?

GSK stock was sold by a variety of institutional investors in the last quarter, including Royal Bank of Canada, Credit Suisse AG, Price T Rowe Associates Inc. MD, Hotchkis & Wiley Capital Management LLC, Northern Trust Corp, Susquehanna International Group LLP, State Street Corp, and Haverford Trust Co..
View insider buying and selling activity for GlaxoSmithKline or view top insider-selling stocks.

Which institutional investors are buying GlaxoSmithKline stock?

GSK stock was bought by a variety of institutional investors in the last quarter, including JTC Employer Solutions Trusteee Ltd, BNP Paribas Arbitrage SA, Capital International Investors, Goldman Sachs Group Inc., Fisher Asset Management LLC, Millennium Management LLC, SG Americas Securities LLC, and Black Creek Investment Management Inc..
View insider buying and selling activity for GlaxoSmithKline or or view top insider-buying stocks.

How do I buy shares of GlaxoSmithKline?

Shares of GSK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is GlaxoSmithKline's stock price today?

One share of GSK stock can currently be purchased for approximately $38.39.

How much money does GlaxoSmithKline make?

GlaxoSmithKline has a market capitalization of $103.37 billion and generates $43.79 billion in revenue each year. The pharmaceutical company earns $7.38 billion in net income (profit) each year or $2.98 on an earnings per share basis.

How many employees does GlaxoSmithKline have?

GlaxoSmithKline employs 94,066 workers across the globe.

When was GlaxoSmithKline founded?

GlaxoSmithKline was founded in 2000.

What is GlaxoSmithKline's official website?

The official website for GlaxoSmithKline is www.gsk.com.

Where are GlaxoSmithKline's headquarters?

GlaxoSmithKline is headquartered at 980 GREAT WEST ROAD, BRENTFORD X0, TW8 9GS.

How can I contact GlaxoSmithKline?

GlaxoSmithKline's mailing address is 980 GREAT WEST ROAD, BRENTFORD X0, TW8 9GS. The pharmaceutical company can be reached via phone at 442080475000 or via email at [email protected].